Philadelphia, PA, United States of America

Yvonne Paterson

This inventor holds 45 USPTO granted patents and 11 published patent applications and 12 EPO patents, primarily in Cancer Immunotherapy. Top assignees: University of Pennsylvania, Advaxis, Inc., University of Georgia Research Foundation Inc. Active years: 1998-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yvonne Paterson. Retrieved from https://idiyas.com/inventor/yvonne-paterson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 45 (Patent Applications = 11)

% Patents Active = 80.0

EPO Patents = 12 (Patent Applications = 18)

Average Co-Inventor Count = 2.2

ph-index = 19

Forward Citations = 944(Granted Patents)

Location History:

Philadephia, PA (US) (2014)
Philadelphia, PA (US) (1998 - 2022)

Company Filing History:

43 out of 2,659

University of Pennsylvania

University of Georgia Research Foundation Inc

patents

4. 1 out of 2

University of Philadelphia

patents

5. 1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2022

Loading Chart...

Areas of Expertise:

Angiogenic Factors

Cancer Immunotherapy

Non-Hemolytic LLO Proteins

Antibiotic Resistance

KLK3 Antigen

FOLH1 Antigen

Combination Therapy

Adjuvants

Cervical Cancer

Tumor Treatment

Immunogenicity

HER2/NEU

45 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11446369 - Compositions and methods comprising KLK3 or FOLH1 antigen (2022-09-20),

2. 10695410 - Compositions comprising angiogenic factors and methods of use thereof (2020-06-30),

3. 10426823 - Methods for constructing antibiotic resistance free vaccines (2019-10-01),

4. 10189885 - Non-hemolytic LLO fusion proteins and methods of utilizing same (2019-01-29),

5. 10166276 - Compositions and methods for treatment of non-hodgkins lymphoma (2019-01-01),

6. 10064898 - Listeria-based adjuvants (2018-09-04),

7. 10016617 - Combination immuno therapy and radiotherapy for the treatment of Her-2-positive cancers (2018-07-10),

8. 10010593 - [object Object] (2018-07-03),

9. 9981024 - Compositions comprising angiogenic factors and methods of use thereof (2018-05-29),

10. 9943590 - [object Object] (2018-04-17),

11. 9919038 - Compositions comprising angiogenic factors and methods of use thereof (2018-03-20),

12. 9700608 - Methods for constructing antibiotic resistance free vaccines (2017-07-11),

13. 9549973 - Compositions and methods comprising KLK3 or FOLH1 antigen (2017-01-24),

14. 9499602 - Non-hemolytic LLO fusion proteins and methods of utilizing same (2016-11-22),

15. 9492527 - Methods for constructing antibiotic resistance free vaccines (2016-11-15),

Title: The Innovations of Yvonne Paterson: Pioneering Medical Breakthroughs

Introduction:

Yvonne Paterson, a remarkable inventor based in Philadelphia, PA, has left an indelible mark in the field of medical research with her groundbreaking inventions. With a total of 45 patents to her name, Paterson has continuously pushed the boundaries of innovation in the healthcare sector.

Latest Patents:

Among her latest patents is the creation of compositions and methods involving KLK3 or FOLH1 antigens. These peptides, along with recombinant polypeptides, nucleotide molecules, and immunogenic and therapeutic methods developed by Paterson, hold promise for advancing cancer treatments. Additionally, her work on compositions containing angiogenic factors showcases her commitment to improving vascular health through innovative means.

Career Highlights:

During her career, Yvonne Paterson has been associated with prestigious institutions such as the University of Pennsylvania and Advaxis, Inc. Her contributions to these renowned organizations have been instrumental in driving forward cutting-edge research in the medical field. Paterson's dedication to her work has not only resulted in numerous patents but also in the development of novel solutions for complex medical challenges.

Collaborations:

Throughout her journey as an inventor, Yvonne Paterson has collaborated with visionary individuals like Paulo Cesar Maciag and Matthew Seavey. These partnerships have been vital in bringing her innovative ideas to life and fostering a collaborative spirit within the research community.

Conclusion:

In conclusion, Yvonne Paterson's passion for innovation and her relentless pursuit of scientific excellence have cemented her legacy as a trailblazer in the realm of medical inventions. Her patents stand as a testament to her unwavering commitment to improving healthcare outcomes and reshaping the future of medicine. As she continues to push the boundaries of what is possible, the world eagerly anticipates the next wave of breakthroughs that will undoubtedly emerge from her creative genius.

Profile summary based on public USPTO records.